PharmaResearch Co Ltd
KOSDAQ:214450
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
89 100
235 500
|
Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
PharmaResearch Co Ltd
Net Issuance of Debt
PharmaResearch Co Ltd
Net Issuance of Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
Net Issuance of Debt
-â‚©8.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Celltrion Inc
KRX:068270
|
Net Issuance of Debt
-â‚©105.7B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
||
SK Bioscience Co Ltd
KRX:302440
|
Net Issuance of Debt
-â‚©95.5B
|
CAGR 3-Years
-326%
|
CAGR 5-Years
-57%
|
CAGR 10-Years
N/A
|
||
Green Cross Corp
KRX:006280
|
Net Issuance of Debt
â‚©101.8B
|
CAGR 3-Years
18%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
||
H
|
Hugel Inc
KOSDAQ:145020
|
Net Issuance of Debt
-â‚©2.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
|
Alteogen Inc
KOSDAQ:196170
|
Net Issuance of Debt
â‚©14.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
PharmaResearch Co Ltd
Glance View
PharmaResearch Co., Ltd. engages in the research and development of refined raw materials for cell and tissue regeneration through marine bio technology. The company is headquartered in Gangneung, Gangwon-Do. The company went IPO on 2015-07-24. The firm produces and sells regenerated products such as pharmaceuticals, medical devices, and cosmetics. In addition, the Company is involved in the venture investment and real estate leasing. The firm mainly provides its products in domestic market.
See Also
What is PharmaResearch Co Ltd's Net Issuance of Debt?
Net Issuance of Debt
-8.6B
KRW
Based on the financial report for Jun 30, 2024, PharmaResearch Co Ltd's Net Issuance of Debt amounts to -8.6B KRW.
What is PharmaResearch Co Ltd's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
19%
Over the last year, the Net Issuance of Debt growth was -297%.